MedWatch

The Leo Foundation to provide larger research grants

In its new strategy, Danish Leo Foundation devotes itself to the active ownership of Leo Pharma and to providing research grants of a much larger scale than previously.

Foto: Leo Fondet

The new strategy of Leo Foundation calls for a more systematic allocation of the fund's research grants.

This is according to CEO Jesper Maillind and Chief Grant Officer Ida Brams. One year after the reorganization of the foundation, they are finally ready for presenting the future strategy.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier